Jump to content

Worta McCaskill-Stevens

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by TJMSmith (talk | contribs) at 15:26, 29 October 2022 (name). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Worta McCaskill-Stevens
Born
Alma materWashington University in St. Louis
American College of Switzerland
Georgetown University School of Medicine
Scientific career
FieldsMedical oncology, clinical trials
InstitutionsNational Cancer Institute

Worta J. McCaskill-Stevens is an American physician-scientist and medical oncologist specialized in cancer disparities research, management of comorbidities within clinical trials, and molecular research for cancer prevention interventions. She is chief of the community oncology and prevention trials research group at the National Cancer Institute.

Early life and education

McCaskill-Stevens was born in Louisburg, North Carolina.[1] She attended Washington University in St. Louis and the American College of Switzerland.[2] McCaskill-Stevens worked as an intern for Time and as a medical editor for Marcel Dekker and the Guttmacher Institute.[3] At Georgetown University School of Medicine, she started medical school at the age of 30, earning a M.D. in 1985 and completing an internal medicine residency. McCaskill-Stevens did a medical oncology fellowship at the Mayo Clinic.[2][3]

Career and research

McCaskill-Stevens at the National Cancer Institute pre-2013.

McCaskill-Stevens, a medical oncologist, joined the National Cancer Institute (NCI) in 1998 as the program director for the study of tamoxifen and raloxifene (STAR), and assumed responsibilities for breast cancer prevention with the community clinical oncology program (CCOP). She chaired the 2009 National Institutes of Health (NIH) State-of-the Science Conference on ductal carcinoma in situ; is a member of the early breast cancer clinical trialist group in Oxford; and is a member of NCI’s breast cancer steering committee. McCaskill-Stevens co-directed the breast care and research center at the Indiana University Cancer Center.[2]

McCaskill-Stevens is chief of the community oncology and prevention trials research group, which houses the NCI community oncology research program (NCORP), a community-based clinical trials network launched in 2014. As NCORP director, she oversees the program supporting community hospitals, physicians and others to participate in NCI-approved cancer treatment, prevention, screening, and control clinical trials, as well as cancer care delivery studies.[2]

McCaskill-Stevens' interests include cancer disparities research both nationally and internationally, management of comorbidities within clinical trials and molecular research that helps to identify those individuals who will best benefit from cancer prevention interventions.[2] She worked with the Study of Tamoxifen and Raloxifene (STAR), as the program director.[4]

Awards and honors

In 2016, she was the recipient of the American Association for Cancer Research Jane Cooke Wright Memorial Lectureship. Her other honors and awards include: the Kaiser Family Fund Award for Excellence in Academic Achievement and Leadership in Medicine; Omega Alpha Medical Honor Society; the NIH Director’s Award for Clinical Trials; the NCI Merit Award for breast cancer prevention; and listed on Ebony’s 2013 Power 100 – Most Influential African Americans in Science and Health.[2] In 2017, she received an honorary Doctor of Science from her alma mater, Georgetown University.[3] McCaskill-Stevens was the recipient of the 2020 ACCC David King Community Clinical Scientist Award, from The Association of Community Cancer Centers (ACCC).[5] Winners of the prestigious David King Award have "demonstrated leadership in the development, participation, and evaluation of clinical studies and/or are active in the development of new screening, risk assessment, treatment, or supportive care programs for cancer patients."[6]

References

  1. ^ "Worta McCaskill-Stevens | Office of Equity, Diversity and Inclusion". www.edi.nih.gov. Retrieved 2021-01-02.Public Domain This article incorporates text from this source, which is in the public domain.
  2. ^ a b c d e f "Worta McCaskill-Stevens, M.D., M.S." Division of Cancer Prevention. 2014-08-13. Retrieved 2021-01-02.Public Domain This article incorporates text from this source, which is in the public domain.
  3. ^ a b c Twombly, Renee (2017-05-08). "McCaskill-Stevens to Address Graduates at School of Medicine Commencement". Georgetown University Medical Center. Retrieved 2021-01-02.{{cite web}}: CS1 maint: url-status (link)
  4. ^ "Worta McCaskill-Stevens | Office of Equity, Diversity and Inclusion". www.edi.nih.gov. Retrieved 2022-02-22.
  5. ^ "Worta McCaskill-Stevens, MD, MS, Named 2020 ACCC David King Community Clinical Scientist Award Winner". /. Retrieved 2022-02-22.
  6. ^ "David King Community Clinical Scientist Award". /. Retrieved 2022-02-22.
Public Domain This article incorporates public domain material from websites or documents of the National Institutes of Health.